Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 2 human prescription drug, 1 human otc drug. By marketing category: ANDA 2, OTC MONOGRAPH DRUG 1.
| Dosage form | NDCs |
|---|---|
| tablet | 2 |
| capsule, liquid filled | 1 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| terrain pharmaceuticals, inc. | 2 |
| terrain pharmaceuticals | 1 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Meloxicam | Meloxicam | tablet, oral | 53225-3015ANDA |
| Meloxicam | Meloxicam | tablet, oral | 53225-3075ANDA |
| Prolaxa | Docusate Sodium 250mg | capsule, liquid filled, oral | 53225-2001OTC MONOGRAPH DRUG |
Compare
Other companies listing meloxicam
- Lupin Limited14 sites · 506 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Ipca Laboratories Limited7 sites · 77 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Unichem Laboratories Limited, India5 sites · 272 NDC
- Arch Pharmalabs Limited3 sites · 12 NDC
- Apex Healthcare Limited3 sites · 11 NDC
Enquiry
Common questions
- Is Terrain Pharmaceuticals, Inc. FDA approved?
- Terrain Pharmaceuticals, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Terrain Pharmaceuticals, Inc. make?
- 3 products are listed under Terrain Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.